InvestSMART

Adherium Limited (ASX:ADR)

ALERT: Price-sensitive ASX Announcement for ADR
Current share price for ADR : $0.110 0.108 (5,400%)+
Announcement
Release
29 Jun 2026 1:45PM
Price at Release
$0.002
Full Release
download
Summary
Adherium Limited has secured a short-term unsecured loan of USD$1.65 million from its major shareholder, Trudell Medical Limited, to meet immediate working capital requirements. The loan, which bears an interest rate of 12% per annum capitalized monthly, is due for repayment on 30 September 2026, with provisions for extension. Adherium has chosen this loan facility due to the limited availability of favorable alternative funding options. The board, excluding Mr. George Baran associated with Trudell, considers the terms fair and consistent with similar market loans, thus not necessitating shareholder approval.
Key Points
  • Adherium Limited received a USD$1.65 million short-term unsecured loan from Trudell Medical Limited.
  • The loan is for working capital requirements and does not dilute existing shareholders.
  • Interest on the loan is 12% per annum, capitalized monthly.
  • The loan is repayable by 30 September 2026, with the option for extension on a month-to-month basis.
  • The loan facility is unsecured and can be repaid at any time without penalty.
  • Adherium opted for this loan facility due to limited and less favorable alternative funding options.
  • The board considers the loan terms to be negotiated at arm's length and does not require shareholder approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.